Hepatic fibrosis and liver metastasis after resection for pancreatic ductal adenocarcinoma

Hepatic fibrosis and liver metastasis after resection for pancreatic ductal adenocarcinoma - StiffLiv

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00023191

Enrollment

100

Registered

2021-09-09

Start date

2021-09-20

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C25.9 K74.0

Interventions

Group 1: Patients receiving resection for pancreatic cancer

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: suspected pancreatic cancer; no suspected distant metasases; no suspected locally advanced tumor stage; age > 18 years no neoadjuvant chemotherapy; ASA 3 or lower; informed written consent

Exclusion criteria

Exclusion criteria: no informed consent; distant metastases; locally advanced disease

Design outcomes

Primary

Measure	Time frame
Metachronous hepatic metastases 1 year after resection as determined by computed tomography and serum Ca 19-9	—

Secondary

Measure	Time frame
Local recurrence 1 year after resection as determined by computed tomography and serum Ca 19-9; postoperative complication rate and intraoperative blood loss	—

Countries

Germany

Contacts

Public ContactThilo Hackert

Department of Surgery

thilo.hackert@med.uni-heidelberg.de00496221566220

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026